Literature DB >> 19156529

Interactions between cycloguanil derivatives and wild type and resistance-associated mutant Plasmodium falciparum dihydrofolate reductases.

Phornphimon Maitarad1, Sumalee Kamchonwongpaisan, Jarunee Vanichtanankul, Tirayut Vilaivan, Yongyuth Yuthavong, Supa Hannongbua.   

Abstract

Comparative molecular field analysis (CoMFA) and quantum chemical calculations were performed on cycloguanil (Cyc) derivatives of the wild type and the quadruple mutant (Asn51Ile, Cys59Arg, Ser108Asn, Ile164Leu) of Plasmodium falciparum dihydrofolate reductase (PfDHFR). The represented CoMFA models of wild type (r(2) = 0.727 and r(2) = 0.985) and mutant type (r(2) = 0.786 and r(2) = 0.979) can describe the differences of the Cyc structural requirements for the two types of PfDHFR enzymes and can be useful to guide the design of new inhibitors. Moreover, the obtained particular interaction energies between the Cyc and the surrounding residues in the binding pocket indicated that Asn108 of mutant enzyme was the cause of Cyc resistance by producing steric clash with p-Cl of Cyc. Consequently, comparing the energy contributions with the potent flexible WR99210 inhibitor, it was found that the key mutant residue, Asn108, demonstrates attractive interaction with this inhibitor and some residues, Leu46, Ile112, Pro113, Phe116, and Leu119, seem to perform as second binding site with WR99210. Therefore, quantum chemical calculations can be useful for investigating residue interactions to clarify the cause of drug resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19156529     DOI: 10.1007/s10822-008-9254-z

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  23 in total

1.  Basis for antifolate action and resistance in malaria.

Authors:  Yongyuth Yuthavong
Journal:  Microbes Infect       Date:  2002-02       Impact factor: 2.700

2.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

Authors:  R D Cramer; D E Patterson; J D Bunce
Journal:  J Am Chem Soc       Date:  1988-08-01       Impact factor: 15.419

Review 3.  The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance.

Authors:  Ian M Hastings; Martin J Donnelly
Journal:  Drug Resist Updat       Date:  2005-04-18       Impact factor: 18.500

Review 4.  The past, present and future of antifolates in the treatment of Plasmodium falciparum infection.

Authors:  Alexis Nzila
Journal:  J Antimicrob Chemother       Date:  2006-04-14       Impact factor: 5.790

Review 5.  Inhibitors of de novo folate enzymes in Plasmodium falciparum.

Authors:  Alexis Nzila
Journal:  Drug Discov Today       Date:  2006-09-07       Impact factor: 7.851

6.  Chemical synthesis of the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene.

Authors:  P Prapunwattana; W Sirawaraporn; Y Yuthavong; D V Santi
Journal:  Mol Biochem Parasitol       Date:  1996-12-02       Impact factor: 1.759

7.  Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: structural basis of antifolate resistance.

Authors:  G Rastelli; W Sirawaraporn; P Sompornpisut; T Vilaivan; S Kamchonwongpaisan; R Quarrell; G Lowe; Y Thebtaranonth; Y Yuthavong
Journal:  Bioorg Med Chem       Date:  2000-05       Impact factor: 3.641

Review 8.  Folate metabolism as a source of molecular targets for antimalarials.

Authors:  Yongyuth Yuthavong; Sumalee Kamchonwongpaisan; Ubolsree Leartsakulpanich; Penchit Chitnumsub
Journal:  Future Microbiol       Date:  2006-06       Impact factor: 3.165

9.  Particular interaction between pyrimethamine derivatives and quadruple mutant type dihydrofolate reductase of Plasmodium falciparum: CoMFA and quantum chemical calculations studies.

Authors:  Phornphimon Maitarad; Patchreenart Saparpakorn; Supa Hannongbua; Sumalee Kamchonwongpaisan; Bongkoch Tarnchompoo; Yongyuth Yuthavong
Journal:  J Enzyme Inhib Med Chem       Date:  2009-04       Impact factor: 5.051

10.  Probing the role of parasite-specific, distant structural regions on communication and catalysis in the bifunctional thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum.

Authors:  Tina Dasgupta; Karen S Anderson
Journal:  Biochemistry       Date:  2008-01-12       Impact factor: 3.162

View more
  5 in total

1.  A virtual screen discovers novel, fragment-sized inhibitors of Mycobacterium tuberculosis InhA.

Authors:  Alexander L Perryman; Weixuan Yu; Xin Wang; Sean Ekins; Stefano Forli; Shao-Gang Li; Joel S Freundlich; Peter J Tonge; Arthur J Olson
Journal:  J Chem Inf Model       Date:  2015-02-17       Impact factor: 4.956

2.  Computer-aided molecular design of 1H-imidazole-2,4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme.

Authors:  Legesse Adane; Prasad V Bharatam
Journal:  J Mol Model       Date:  2010-06-05       Impact factor: 1.810

3.  Key role of hydrazine to the interaction between oxaloacetic against phosphoenolpyruvic carboxykinase (PEPCK): ONIOM calculations.

Authors:  Pongthep Prajongtat; Darinee Sae-Tang Phromyothin; Supa Hannongbua
Journal:  J Mol Model       Date:  2013-04-27       Impact factor: 1.810

4.  Ligand binding studies, preliminary structure-activity relationship and detailed mechanistic characterization of 1-phenyl-6,6-dimethyl-1,3,5-triazine-2,4-diamine derivatives as inhibitors of Escherichia coli dihydrofolate reductase.

Authors:  Bharath Srinivasan; Sam Tonddast-Navaei; Jeffrey Skolnick
Journal:  Eur J Med Chem       Date:  2015-09-05       Impact factor: 6.514

5.  Binding modes of 2,4-diaminoquinazoline and 2,4-diaminopteridine analogs to P. falciparum dihydrofolate reductase enzyme: Molecular docking studies.

Authors:  L Adane; P V Bharatam
Journal:  Indian J Pharm Sci       Date:  2010-05       Impact factor: 0.975

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.